Humanigen Inc (OTCMKTS:HGEN)

Humanigen Inc (OTCMKTS:HGEN)


Share Price
$ 1.07
Change
-0.072 (-6.30 %)
Market Cap
$117.94 m
Proactive Investors - Run By Investors For Investors

Humanigen Inc

Humanigen develops biologics to improve CAR-T and other breakthrough oncology treatments. Lenzilumab is a product that has the potential to both improve the efficacy and safety associated with CAR-T therapy in oncology. We are developing lenzilumab in close collaboration with the leading and most experienced centers in the CAR-T field. We are exploring partnerships with established and...

EPIC: HGEN
Market: OTCQB:HGEN
52-week High/Low: $1.54 / $0.27
Sector: Pharma & Biotech
Market Cap: $117.94 m
Website: www.humanigen.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Humanigen Inc


Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use